Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

Certain DNA sequences can form structures other than the canonical double helix. These alternative DNA conformations—referred ...

In a nutshell Drugs processed by the liver can become significantly more toxic to brain cells than when directly exposed to ...

Seaport Therapeutics, a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the presentation of new preclinical ...

The molecular mechanism behind why heart attacks can vary in severity depending on the time of day has been uncovered by ...

A Tennessee family has opened up about their young daughter's devastating battle with a rare disorder that has caused her to ...

Regular physical activity, such as dance or targeted exercise, can slow the progression of Parkinson’s disease, helping ...

Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in ...

It was a packed house at Yee-Haw Brewing in North Knoxville as hundreds gathered to show their support for the Begbie family and others who have children with Sanfilippo Syndrome.

In the microscopic battlefield of plant-microbe interactions, plants are constantly fighting off invading bacteria. New research reveals just how clever these bacterial invaders can be.

An editorial published in Brain Medicine reveals that many widely prescribed medications may disrupt sterol biosynthesis—an essential process for brain development—potentially causing harm similar to ...

A preclinical study from scientists at Scripps Research finds that a drug already FDA-approved for treating inflammatory conditions may help reduce both alcohol intake and pain sensitivity-two issues ...